Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/2003
12/18/2003WO2003104443A2 Hair follicle mesenchymal stem cells and use thereof
12/18/2003WO2003104441A2 Novel bacterial strain, compositions derived therefrom and methods of using same for treating beta-ap-associated deseases
12/18/2003WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor
12/18/2003WO2003103720A2 Compositions and methods for the use of bcl-2 transfected neurons
12/18/2003WO2003103705A1 Metalloproteinase inhibitors
12/18/2003WO2003103611A2 Methods and compositions for the repair and/or regeneration of damaged myocardium
12/18/2003WO2003103581A2 Compositions and methods for liver growth and liver protection
12/18/2003WO2003103578A2 Bacteriophage and enzymes lytic to salmonellae
12/18/2003WO2003103390A1 Sterilization, stabilization and preservation of functional biologics
12/18/2003WO2003103389A2 Cryopreservation of haptenized tumor cells
12/18/2003WO2003097052A3 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
12/18/2003WO2003085097B1 Method of preparing a probiotic preparation
12/18/2003WO2003082302A3 Bioadhesive directed somatic cell therapy
12/18/2003WO2003057911A3 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
12/18/2003WO2003042405A3 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
12/18/2003WO2003025149A3 Cell populations which co-express cd49c and cd90
12/18/2003WO2003024297A3 Cell storage and delivery system
12/18/2003WO2003016540A3 Humanised baculovirus
12/18/2003WO2003014342A3 Identification of a dna variant associated with adult type hypolactasia
12/18/2003WO2002099035A3 Chimeric alphavirus replicon particles
12/18/2003WO2002079456B1 A method for the preparation of immunologically inert amniotic membranes
12/18/2003WO2002079388A3 Modulation of mhc class i antigen presentation
12/18/2003WO2002078599A3 CD8α + LYMPHOID DENDRITIC CELL DIFFERENTIATED FROM HUMAN HEMATOPOIETIC STEM CELL AND A METHOD FOR DIFFERENTIATION
12/18/2003WO2002074157A3 A mammalian immortalized liver cell
12/18/2003WO2002030257A9 Normalization of defective t cell responsiveness through manipulation of thymic regeneration
12/18/2003WO2002007678A3 Mu-conopeptides
12/18/2003US20030232752 Proliferated cell lines and uses thereof
12/18/2003US20030232433 The use of stem cells and CD6 depleted stem cells for the induction of tolerance to allogenic transplants and/or for the treatment of leucemia
12/18/2003US20030232431 Cellular transplantation for heart regeneration
12/18/2003US20030232430 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
12/18/2003US20030232058 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
12/18/2003US20030232057 Method and composition for inducing tolerance to an antigenic material
12/18/2003US20030232050 Compositions and methods for regulating angiogenesis
12/18/2003US20030232045 Methods and compositions for in vivo clearance of pathogens
12/18/2003US20030232036 Alphavirus RNA replicon systems
12/18/2003US20030232018 Stabilized formulations of adenovirus
12/18/2003CA2489076A1 Cryopreservation of haptenized tumor cells
12/18/2003CA2488744A1 Compositions and methods for the use of bcl-2 transfected neurons
12/18/2003CA2488429A1 Generation of neural stem cells from undifferentiated human embryonic stem cells
12/18/2003CA2488346A1 Methods and compositions for the repair and/or regeneration of damaged myocardium
12/18/2003CA2488227A1 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
12/18/2003CA2488057A1 Hair follicle mesenchymal stem cells and use thereof
12/18/2003CA2487826A1 Sterilization, stabilization and preservation of functional biologics
12/18/2003CA2487418A1 Metalloproteinase inhibitors
12/18/2003CA2486270A1 Vegfr modulating agents and methods for liver growth and liver protection
12/18/2003CA2432753A1 Feed additives for animals: prevention of foot and mouth disease
12/17/2003EP1371730A2 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
12/17/2003EP1371664A1 Wti modified peptide
12/17/2003EP1371660A1 Vaccine
12/17/2003EP1371377A1 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
12/17/2003EP1370676A2 Mouse cytokine receptor
12/17/2003EP1370661A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
12/17/2003EP1370643A1 Method of extracting virus from cell culture
12/17/2003EP1370642A2 Pluripotent adult stem cells derived from regenerative tissue
12/17/2003EP1370641A2 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia
12/17/2003EP1370640A1 Lactic acid bacteria as agents for treating and preventing allergy
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370585A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370579A1 Matrix gene expression in chondrogenesis
12/17/2003EP1370290A2 Molecular antigen array
12/17/2003EP1370283A2 Prevention of recurrent viral disease
12/17/2003EP1370237A2 Presbyopia treatment by lens alteration
12/17/2003EP1370194A2 Composition and methods fro the production of biological tissues and tissue constructs
12/17/2003EP1182926B1 Method of cryopreservation of blood vessels by vitrification
12/17/2003CN1462309A Codon-optimized papilloma virus sequences
12/17/2003CN1462195A Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same
12/17/2003CN1462190A The use of copolymer 1 and related peptides and polypeptides and T cell treated therewith for neuroprotective therapy
12/17/2003CN1461645A 鳄鱼油丸 Crocodile oil pills
12/17/2003CN1131069C Anti-disease silk increasing agent for silk worm
12/17/2003CN1131065C Medicine for treating hemipara lysis, obstruction of qi in the chest and cardialgia
12/17/2003CN1131064C Medicine for yang-strengthening and kidney-invigorating
12/17/2003CN1131063C Medicine for kidney invigorating and yang strenthening and its preparation method
12/17/2003CN1131061C Prepn. method for medicine liquid for treating piles
12/17/2003CN1131059C Life-prolonging tea
12/17/2003CN1131056C Hypoglycemic deep-rooted ulcer eliminating medicine
12/17/2003CN1131055C Tincture for treating leucoderma and preparation method and application thereof
12/17/2003CN1131053C Chinese medicine for treating diabetes
12/17/2003CN1131048C Medicine for treating blood vessel of heart and brain and preparation method thereof
12/17/2003CN1131047C Ointment for treating spinal hyperosteogeny
12/17/2003CN1131046C Chinese medicine for treating baby pneumonia
12/17/2003CN1131042C Bee glue preparation for treating stomatocace and its compounding process
12/17/2003CN1131041C Preparing process for instant aminoacid-calcium particles
12/17/2003CN1130975C Preparation of biochemical pesticide for preventing and kilting water flea
12/16/2003US6664096 Nutrient broths for use in the propagation of microorganism
12/16/2003US6663884 Method of detoxifying the egg of puffer fish for creating healthy foodstuffs and the resulting product
12/16/2003US6663872 Immune response
12/16/2003US6663871 Non-replicating or replication- impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition, malaria
12/16/2003US6663859 Compositions for enhancing the immune response
12/16/2003US6663856 Gene therapy
12/16/2003US6662805 Method for composite cell-based implants
12/16/2003CA2251983C Regeneration and augmentation of bone using mesenchymal stem cells
12/16/2003CA2043527C Biocompatible perforated membranes, processes for their preparation, and uses thereof
12/14/2003CA2430259A1 Vaccine
12/11/2003WO2003102171A1 Expansion and transdifferentiation of human acinar cells
12/11/2003WO2003102169A1 Anaerobe targeted enzyme-mediated prodrug therapy
12/11/2003WO2003102162A2 Novel tolerogenic dendritic cells and therapeutic uses therefor
12/11/2003WO2003102151A2 Modulating cell differentiation and treating myeloprolifertive disorders with jnk/mkk inhibitors
12/11/2003WO2003102135A2 Control sequences of the human corin gene
12/11/2003WO2003102134A2 Pancreatic acinar cells into insulin producing cells